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Intrinsically Photosensitive (Melanopsin) Retinal
Ganglion Cell Function in Glaucoma
Beatrix Feigl,1,2 Dietmar Mattes,3 Ravi Thomas,2 and Andrew J. Zele1
PURPOSE. To determine whether glaucoma alters intrinsically
photosensitive retinal ganglion cell (ipRGC) function.
METHODS. Forty-one patients (25 with glaucoma and 16
healthy age-matched control participants) were tested. In-
trinsically photosensitive retinal ganglion cell function was
directly measured by the sustained, postillumination pupil
response (PIPR). Forty-one eyes of 41 participants were
tested with 7°, 10-second, short-wavelength (488 nm; blu-
ish) and long-wavelength (610 nm; reddish) stimuli (14.2 log
photons  cm2  s1) presented to the right eye in Max-
wellian view, and the consensual pupil response of the left
eye was measured by infrared pupillometry. The difference
between PIPR amplitude (percentage baseline pupil diame-
ter), net PIPR (percentage change) and kinetics (time in
mm  s1 to the PIPR plateau) for the blue and red stimuli in
patients with early and advanced (moderate/severe) glau-
coma was compared to that in age-matched control partici-
pants.
RESULTS. The blue PIPR was significantly smaller between nor-
mal participants and patients with advanced glaucoma, as well
as between those with early and those with advanced glau-
coma (P  0.05). The kinetics of the red and blue PIPRs were
not significantly different between any groups. Normal age-
matched participants and patients with early-stage glaucoma
were not significantly different on any parameter, and neither
was the normal and glaucoma group (advanced and early
combined).
CONCLUSIONS. Persons with moderate and severe glaucoma have
a dysfunctional ipRGC-mediated PIPR. Intrinsically photosensi-
tive retinal ganglion cell function measured directly with the
PIPR may become a clinical indicator of progressive changes in
glaucoma. (Invest Ophthalmol Vis Sci. 2011;52:4362–4367)
DOI:10.1167/iovs.10-7069
The pupillary light reflex is a fundamental diagnostic toolfor the assessment of afferent and efferent defects in
neuroophthalmic disorders.1 The recently discovered intrin-
sically photosensitive retinal ganglion cells (ipRGCs) di-
rectly contribute to the postillumination pupil response
(PIPR) as a sustained constriction (30 seconds) of the
pupillary light reflex2,4 – 6 after offset of high retinal irradi-
ance (half-maximum, 13.6 log photons  cm2  s1), short
wavelength light (ipRGC peak spectral sensitivity,
482nm).2 In vitro recordings in macaque and human reti-
nas showed that ipRGCs display a typical transient increase
in firing rate at stimulus onset and a unique sustained firing
that continues after light offset.3 It is this sustained, intrinsic
ipRGC photoresponse that controls the PIPR.2 The ipRGCs
are sparse (3000; approximately 0.2% of all ganglion cells),
have the longest dendrites and largest somata of all known
ganglion cell types (diameters of 350 to 1200 m, increasing
with retinal eccentricity), are mainly located in the ganglion
cell layer, and are at peak density in the paracentral retina
(2°)3 (for review see, Markwell et al.4). The normal func-
tional ipRGC-mediated PIPR range has been determined in a
sample of healthy persons, and the PIPR magnitude was
independent of age, race, or sex and shows high repeatabil-
ity.5 However, its potential use in disease detection and
management is still to be determined and may open a new
view of the pupillary light reflex in the diagnosis and mon-
itoring of a wider range of retinal and optic nerve diseases.
Investigations in a few reports indicated that the pupillary
light reflex can be used to differentiate outer and inner
retinal function in disease by appropriate choice of stimulus
wavelength and intensity.4 – 6,7 For example, outer and inner
retinal contributions to the pupillary light reflex can be
determined by varying the intensity of a reddish (long-
wavelength) or bluish (short-wavelength) light. Indeed, with
such stimuli, deficits in retinitis pigmentosa4,6 – 8 and ante-
rior ischemic neuropathy6 have been identified.
In vitro evidence from flat-mounted rat retinas suggests
that chronic ocular hypertension induced over 12 weeks
does not produce observable ipRGC morphologic changes
or cell loss, whereas non–melanopsin-labeled superior col-
liculus projecting retinal ganglion cells do exhibit significant
loss.9 It was inferred that ipRGCs have a high cellular resis-
tance to injury-induced damage.9 In another study using a rat
model of ocular hypertension, reduced ipRGC density was
found, but there was no change in soma size and dendritic
morphology in the remaining ipRGCs.10 There is, however,
anecdotal evidence showing no immunoreactivity of the
ipRGC photopigment melanopsin in one patient with long-
standing glaucoma.11 Moreover, patients with advanced
glaucoma show reduced melatonin suppression, implying
that ipRGC function may be affected.12 Recently Kankipati
et al.13 demonstrated reduced ipRGC-mediated PIPR func-
tion in glaucomatous optic neuropathy, but did not investi-
gate the PIPR in early stages of glaucoma, nor did they study
pupil kinetics. In the present study we determined whether
the PIPR (amplitude and kinetics) is dysfunctional in pa-
tients with early, moderate, or severe glaucoma compared
with an age-matched control group.
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PARTICIPANTS AND METHODS
Participants
All 41 participants underwent a comprehensive ophthalmic examina-
tion including best corrected visual acuity, anterior eye slit lamp
biomicroscopy, gonioscopy, intraocular pressure measured with Gold-
man applanation tonometry and ophthalmoscopy by one of the three
eye specialists (BF, DM, and RT). Of these, 25 were glaucoma patients
(age range, 31–78 years, mean  SD, 60  11.7; 15 men and 10
women) recruited from a glaucoma specialist practice (RT) where they
had undergone testing for glaucoma, including conventional visual
fields (Humphrey 30-2, Humphrey Field Analyzer, HFA; Carl Zeiss
Meditec, Inc. Dublin, CA). Patient characteristics are outlined in Table 1.
Glaucoma was defined by an intraocular pressure of 21 mm Hg
before the beginning of the pressure-lowering therapy, combination of
optic disc changes typical of glaucoma (neuroretinal rim thinning, loss
of inferior superior temporal nasal [ISTN] rule, notch, disc hemor-
rhage, nerve fiber layer defect), with or without characteristic visual
field defects; secondary glaucoma was excluded. All glaucomatous
eyes were phakic, with lens densities1 (for nuclear, subcapsular, and
cortical cataracts) according to the Age Related Eye Disease Study
Research Group (AREDS) classification.14 One patient (G20) had un-
dergone cataract surgery and intraocular lens (IOL) implantation in the
right eye. This patients’ right pupil could be fully dilated (7 mm). All
patients had visual acuity of 6/7.5 or better in the right eyes. Nineteen
glaucoma patients had received pressure-lowering topical treatment in
both eyes, five patients had topical treatment in only one eye (four in
the right eye and one in the left eye), and one patient (G16) had no
treatment.
Sixteen healthy participants without ocular disease (age range,
30–72 years, mean  SD 58  12.9) served as the age-matched normal
control group and were randomly selected from a university cohort.
The control participants had no morphologic or functional damage
indicating glaucoma and were matched to cases by age (5 years).
Medical history including diabetes mellitus, hypertension, general med-
ications, and sleep disorders were documented. Patients with preex-
isting inner retinal disorders, due to, for example, diabetes or optic
neuritis, were excluded. In the control group, all persons were phakic,
except for one who had undergone cataract surgery and IOL implan-
tation and was age-matched to the pseudophakic glaucoma patient
(G20).
Informed consent was obtained from all participants, and the study
was conducted in accordance with the requirements of Queensland
University of Technology Human Research Ethics Committee and the
tenets of the Declaration of Helsinki.
Pupillometry
The consensual pupillary light reflex of the left eye was recorded with
an infrared camera (Pixelink; IEEE-1394, PL-A741 FireWire; 480  640
pixels; 62 frames  sec1) through a telecentric lens (Computar 2/3 in;
55-mm and 2 extender C-Mount; CBC, Tokyo, Japan) in response to
a calibrated, monochromatic, 14.2 log photon  cm2  s1,10-second,
7.15° stimulus (488 nm, 610 nm; 10–12 nm full-width at half maxi-
mum; Edmund Optics, Barrington, NJ) presented to the right eye with
a Maxwellian view optical system, controlled and analyzed with cus-
tom software (MatLab; The MathWorks, Natick, MA).4 The viewing
distance (1.15 m) of the 6.3°  8.9° back-lit fixation screen (3.6 cd 
m2) for the consensual left eye was determined by a control study, to
minimize accommodation and convergence-driven pupil fluctuations.
Temple bars, head restraint, and chin rest stabilized the head position
in the pupillometer.
Patients with abnormal nuclear, subcapsular, or cortical lens
changes greater than 1 were excluded according to the AREDS classi-
fication.14 To compensate for any change in stimulus retinal irradiance
due to senile miosis and/or age-related optical media changes (AREDS
grade 1),15,16 the stimulus was presented in Maxwellian view, and
corneal irradiance was set to 14.2 log photons  cm2  s1. This
irradiance was chosen based on the retinal irradiance–PIPR functions
measured by Gamlin et al.2 in three individuals at 493 nm between 9
and 15 log photons  cm2  s1. The half-maximum PIPR constriction
was at 13.6 log photons  cm2  s1, with higher irradiances pro-
ducing larger PIPR constrictions until a plateau of 15 log photons 
TABLE 1. Patient Characteristics
Patient ID Sex Age (y)
Duration of Glaucoma
since Diagnosis IOP RE/LE Grading*
G1 M 58 2 Years (POAG) 8/16 Advanced
G3 M 76 7 Years (POAG) 12/15 Advanced
G4 M 71 1 Year (ACG) 13/11 Advanced
G5 F 58 12 Years (POAG) 19/20 Early
G6 M 42 New (POAG) 21/17 Early
G7 M 77 New (POAG) 13/12 Early
G8 M 60 8 Years (POAG) 14/18 Advanced
G10 F 59 New (POAG) 22/15 Early
G11 M 40 1 Months (POAG) 10/16 Advanced
G14 F 57 New (POAG) 18/17 Early
G15 F 67 18 Months (POAG) 18/21 Early
G16 F 60 1 Month (POAG) 18/15 Early
G17 M 70 18 Years (POAG) 8/16 Advanced
G18 F 65 6 Months (POAG) 20/16 Advanced
G19 F 48 4 Years (POAG) 19/20 Early
G20 F 62 20 Years (POAG) 10/12 Advanced
G21 F 62 Unknown (POAG) 19/15 Advanced
G23 M 47 18 Months (POAG) 12/10 Advanced
G24 M 62 18 Months (POAG) 17/17 Early
G25 M 31 13 Years (POAG) 12/11 Early
G26 M 62 18 Months (POAG) 10/10 Early
G27 M 71 1 Year (POAG) 18/13 Early
G28 F 56 2 Weeks (POAG) 17/13 Early
G29 M 54 8 Months (POAG) 15/15 Early
G30 M 78 1 Month (POAG), 24/20 Advanced
* Grading based on MD on SAP (Humphrey perimetry; Carl Zeiss Meditec, Inc., Dublin, CA) and mean
sensitivity on microperimetry (MP-1; Nidek, Padova, Italy).
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cm2  s1 was reached. In this study, the corneal irradiance permits
for an estimated lens density increase of 0.28 log units at 488 nm (0.04
log units at 610 nm) in the oldest participants.17 Therefore, the stim-
ulus and experimental design and matching of controls to patients
minimized the effect of optical changes on the pupillary light reflex.
The short-wavelength stimulus (488 nm) was chosen to maximize
ipRGC contributions to the PIPR,2,4 and the long-wavelength stimulus
(610 nm) was chosen as a control of nonspecific factors such as fatigue
on the PIPR5 and because the ipRGC contribution to the PIPR is
reduced at long wavelengths.2,4,5 Testing was conducted in all patients
during the day, to minimize the circadian variation in the ipRGC-
mediated response.18 Our studies indicate that the within-subject test
reliability was high on the same day and between days,18 consistent
with findings in a previous report.5
Statistical Analysis of the Pupillometer Results
A simple linear and exponential model described the pupillary light
reflex. A linear function (ymx c) with a 0 gradient (m 0) for the
10-second prestimulus duration defined the mean baseline pupil diam-
eter (c). Both, the pupil constriction velocity from light onset to
maximum constriction and the maintained pupil constriction between
maximum constriction and light offset were fitted with linear func-
tions. The kinetics of the PIPR were described by an exponential
function of the form y  S  exp(k  x)  P, where S is a constant, k is
the redilation velocity (global rate constant; GR) in millimeters per
second, x is time in seconds, and P is the sustained plateau pupil
diameter (in millimeters) of the PIPR. The prestimulus baseline pupil
diameter and PIPR values were derived from the best-fitting model
parameters and used for statistical analysis.4 The PIPR was described
according to three parameters. First, to control for the influence of
baseline pupil diameter on PIPR amplitude,5 the percentage PIPR
amplitude was calculated relative to the baseline pupil diameter for the
blue stimulus (blue PIPR) and the red stimulus (red PIPR).4,5 Second,
the net PIPR value (percentage change) was assessed by subtracting
the blue PIPR percentage from the red PIPR percentage.5 Third, the GR
constant (in millimeters per second) from the best-fitting exponential
functions to the blue and red PIPR data estimated the kinetics of
redilation to the sustained PIPR after light offset.
The initial data analysis included the distributions of the variables
that did not show major deviations from normality. The blue PIPR, red
PIPR, blue GR, red GR, and net PIPR were analyzed by using repeated-
measures analysis of variance (RM-ANOVA) and one-way ANOVA. P 
0.05 was considered as significant. Post hoc analysis (LSD) was per-
formed to identify significant group differences.
Microperimetry
Microperimetry was performed with a device (Micorperimeter-MP1;
Nidek Technologies, Padova, Italy) that allows a 45° view of the fundus
during testing. An inbuilt automated tracking system corrects for eye
movements, assuring that the tested retinal location is aligned to the
reference area identified at the start of the examination. The manufac-
turer-customized Humphrey 10-2 program was used, and 68 Goldmann
III stimuli were presented in a 10° test grid with a 4-to-2 staircase
strategy. The background luminance was 1.27 cd  m2, and the
stimulus duration was 100 ms.
Glaucoma Grading
Mean deviation (MD) of standard automated perimetry (SAP) (Hum-
phrey 30-2) and microperimetry (MP) mean sensitivity (MS) of the right
eyes were used to grade glaucoma participants according to two
groups. Humphrey MD less than 6.0 dB19 and MS greater than 15.5
dB on microperimetry (based on our normal age-matched cohort [n 
39]; mean [SD]), 17.9  0.9 dB and published results20) were as-
signed to the early glaucoma group. Patients with Humphrey MD
greater than 6.0 dB and 15.5 dB on microperimetry formed the
advanced glaucoma group where moderate and severe glaucoma cases
were combined based on the MD on Humphrey. The inclusion of
microperimetry in the glaucoma grading is based on a recent finding
that central defects can remain undetected on SAP but are evident on
microperimetry.21 Group 1 (early) consisted of 14 patients (mean age,
57  11.6 years) with glaucomatous disc changes and/or mild defects
on SAP but no central field defects on microperimetry. Group 2
(advanced) consisted of 11 patients (mean age, 63  11.6 years) with
moderate to severe glaucomatous field defects on SAP (MD  6.0 dB)
and/or central defects on microperimetry (MS  15.5 dB). This group
included two patients (G11 and G30) who had central defects on
microperimetry and an MD  6 dB on SAP (with no central deficits).
One patient (G3) could not perform microperimetry due to advanced
visual field defects on SAP and was assigned to group 2. Two further
patients (G24, G27) did not complete microperimetry due to technical
or ocular issues (i.e., concentration, dry eyes) and were assigned to
group 1 based on SAP.
RESULTS
The pupillary light reflex (% baseline pupil diameter) of a
healthy control participant and a patient with advanced glau-
coma (G23) is shown in Figure 1 as a function of time (in
seconds) for the 488 nm (blue; test) and 610 nm (red; control)
stimuli. The pupillary light reflex is composed of the baseline
diameter (10-second prestimulus recording), response latency
(delay in pupil constriction after light onset), maximum con-
striction to the steady state during the 10 seconds light expo-
sure and recovery (redilation after light offset) to the PIPR. In
the healthy participant (Fig. 1A), the sustained PIPR for 20 to
50 seconds after light offset with the blue light stimulus is
controlled by intrinsic ipRGC function. The red PIPR is con-
trolled by outer retinal inputs to ipRGCs and shows a minimal
FIGURE 1. Intrinsically photosensi-
tive retinal ganglion cell contribu-
tions to the pupillary light reflex in
glaucoma. Shown is pupil ampli-
tude (percentage of baseline pupil
diameter) in response to blue 488
nm (blue line, model; black line,
data) and red 610 nm (red line,
model; gray line, data) stimuli
(gray bar). (A) Exemplary pupillary
light reflex of a healthy 55-year-old
person with an 84.6% ipRGC-medi-
ated, sustained PIPR compared
with baseline pupil diameter, indi-
cating normal ipRGC function (net
PIPR change, 14.9%). (B) Exem-
plary pupillary light reflex of a 47-
year-old glaucoma patient with field defects classified as advanced glaucoma (G23). The difference in percentage pupil diameter between
the blue and red PIPRs (net PIPR change) is 5%, indicating ipRGC dysfunction.
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sustained PIPR. In comparison, the glaucoma patient (Fig. 1B)
shows a reduced difference in the net PIPR percentage change,
indicating an alteration in ipRGC function.
To directly compare the individual PIPRs in the controls and
patients, Figure 2 shows the red PIPR (Fig. 2A) and blue PIPR
(Fig. 2B) for the participants in the advanced glaucoma, early
glaucoma, and control groups. The PIPR range in the control
group was consistent with that reported previously.5,6 The
blue PIPR and red PIPR were not significantly different be-
tween the normal and the glaucoma patients (early and ad-
vanced groups combined; F1,39  2.11, P  0.2). There was,
however, a significant main effect of blue PIPR and red PIPR
between the three groups (F2,38  3.67, P  0.04; Table 2).
Post hoc analysis identified a significantly lower blue PIPR in
the advanced group compared with the early glaucoma group
(P  0.03) and compared to the normal group (P  0.02; Fig.
2A). There was no significant difference between early glau-
coma and normal participants (P  0.8). We then analyzed the
net PIPR percentage to examine the difference between the
test (blue) and control (red) measures to correct for the influ-
ence of baseline pupil diameter. This analysis identified a sig-
nificant main effect between the three groups (F2,38  6.02,
P  0.001), showing reduced net PIPR for the advanced group
compared to the early and normal group (P  0.01; Table 2).
To compare the kinetics of the PIPRs in the controls and
patients, Figure 3 shows the global rate constants from the
best-fitting exponential function for the blue PIPR and red PIPR
for the participants in each group. There was no significant
main effect of PIPR kinetics as described by the blue and red
global rate constants (F2,38  0.22, P  0.08; Table 2).
DISCUSSION
We demonstrate that intrinsically photosensitive retinal gan-
glion cell (ipRGC) contributions to the PIPR are altered in
patients with glaucoma. It was observed that ipRGC function
was reduced in advanced glaucoma patients compared with
persons with early glaucoma and persons in the healthy normal
control group. The PIPR global-rate constant estimated the
kinetics of pupil redilation after light offset and was not signif-
icantly different between the glaucoma and control groups.
Our findings of ipRGC dysfunction in humans with advanced
glaucoma suggest a role of this ganglion cell subtype in the
pathomechanisms of progressive disease.
Our observation that the PIPR was not reduced in early
glaucoma is consistent with in vitro ocular hypertension ex-
periments in rats that show that ipRGCs have a high cellular
resistance to injury-induced damage.9 Studies in patients with
toxic neuropathy or hereditary mitochondrial neuropathy also
indicate a robustness of ipRGCs to injury and a neuroprotective
role of pituitary adenylate cyclase-activating polypeptide
(PACAP) has been discussed.22 Melatonin has also been sug-
gested to be neuroprotective in glaucoma because of its anti-
oxidant and antinitridergic properties.23 Although the neuro-
protective mechanisms are still to be determined, the
resistance of ipRGCs to damage may be important, given their
reduced redundancy, and their non–image-forming role in sig-
naling the environmental light levels3 to the central circadian
clock in suprachiasmatic nucleus (SCN) for photoentrain-
ment.24,25 Jean-Louis et al.26 hypothesized that glaucoma
FIGURE 2. Amplitude of the PIPR in glaucoma patients and age-
matched controls. (A) Percentage amplitude of the blue (488 nm) PIPR
relative to baseline pupil diameter for patients with advanced (blue
circles) or early (blue squares) glaucoma and age-matched controls
(blue diamonds). The PIPR was significantly reduced in advanced
glaucoma (n  11), indicating ipRGC dysfunction in this cohort when
compared with patients with early glaucoma and age-matched con-
trols. (B) Percentage amplitude of the red (610 nm) PIPR relative to
baseline pupil diameter for patients with advanced (red circles) or
early (red squares) glaucoma and age-matched controls (blue dia-
monds). Outer retinal photoreceptor inputs to the red PIPR were not
significantly different between groups. Horizontal lines: group mean
values.
TABLE 2. ipRGC Controlled PIPR Parameters
Group
Blue PIPR
Amplitude*
Red PIPR
Amplitude* Net PIPR†
Blue Global Rate
(mm  s1)
Red Global Rate
(mm  s1)
Early 89.0  5.8 97.0  3.3 7.9  5.5 0.4  0.2 0.4  0.2
Advanced 94.8  2.6 97.7  3.1 2.9  2.3 0.3  0.2 0.3  0.2
Control 88.1  3.8 97.4  5.1 9.3  4.9 0.3  0.2 0.4  0.2
Data are expressed as the mean  SD.
* Percentage amplitude relative to baseline pupil diameter.
† Percentage change.
FIGURE 3. GR of the PIPR kinetics in glaucoma patients and age-
matched controls. (A) Global rate of the blue (488 nm) PIPR for
patients with advanced (blue circles) or early (blue squares) glaucoma
and age-similar controls (blue diamonds) shows no significant differ-
ence between groups. (B) The GR of the red (610 nm) PIRP for
patients with advanced (red circles) or early (red squares) glaucoma
and age-matched controls (red diamonds) was not significantly differ-
ent between groups. Horizontal lines: group mean values.
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would provide an opportunity to evaluate whether ganglion
cell loss, in particular ipRGCs, could compromise photic input
to the circadian system. Animal models in rats27 and prelimi-
nary data from a small number of human cases28 suggest that
there may be impairment of the circadian rhythm and melato-
nin secretion in glaucoma. Further research is needed, to
evaluate whether patients with advanced glaucoma have diffi-
culty readjusting to changes in the light–dark environment,
such as traveling across different time zones. An ipRGC resis-
tance to injury, however, could weaken during longstanding
conditions of ocular hypertension or in manifest glaucoma.
The observed ipRGC dysfunction in the advanced cases may
therefore indicate glaucoma progression. In this framework,
dysfunction alters ipRGC irradiance signaling to the pineal
gland, thereby impairing melatonin release, resulting in re-
duced neuroprotection. In our medical evaluation of all partic-
ipants, we informally discussed sleep behavior, and none of
our patients complained of any circadian disturbances. Taken
together, we infer from the patient reports that photic entrain-
ment is still possible in advanced glaucoma patients with
ipRGC dysfunction. However, future studies should determine
patient melatonin levels, evaluate sleep patterns with objective
measures and relate these with different levels of ipRGC dys-
function or loss.
The ipRGC inputs to the pupil response may be nonlinear,
so that a large level of loss or dysfunction is required before the
PIPR is affected. In the absence of a complete irradiance re-
sponse study of the PIPR to determine the threshold ipRGC
number for a normal PIPR, a resistance to injury, as shown in
rodents,9 may not apply in humans. It has been shown, at least
in mice, that photon capture by only a few ipRGCs is required
at the pupil reflex threshold,29 whereas only the slightest pupil
constriction is present after near complete ablation of
ipRGCs.30,31 However, the peak ipRGC density (2° paracen-
tral) is outside the most severely affected areas in glaucoma,
and therefore many macular ipRGCs could remain unaffected
by arcuate defects and only show deficits when glaucomatous
damage has progressed to the center. To account for this latter
hypothesis, patients with severe glaucoma were graded ac-
cording to both the MD on SAP and mean sensitivity on micro-
perimetry, because microperimetry is sensitive to central def-
icits not apparent on SAP.21 Indeed, those participants graded
as advanced had a more impaired PIPR on average than did
patients graded with early glaucoma (and no deficits on micro-
perimetry). This result is in accordance with a recent finding
that shows that as visual field loss increases in severity there is
a reduction in the net PIPR change.13 Our data further indicate
that ipRGC dysfunction in glaucoma can occur in central reti-
nal areas before deficits on SAP. In most of the glaucoma
patients, SAP central visual field performance was relatively
better than in the midperipheral retina (data not shown).
Monitoring glaucoma progression is as important as early
diagnosis and requires precise assessment of functional loss
and structural change relative to baseline measurements. The
gold standard for monitoring functional loss is SAP, and statis-
tical programs are available to assist the ophthalmologist in the
difficult task of assessing progression. While imaging tech-
niques are likely to be useful earlier in the course of disease,32
the monitoring and prognostication for advanced glaucoma is
far more challenging. Visual sensitivity is more variable, testing
requires larger stimuli, and statistical programs to assess pro-
gression for advanced stages are not available. The “macula
split” as demonstrated by the size V target on the macula
program of the Humphrey field analyzer can be used as a crude
measure to assess prognosis of vision and the probability of a
wipeout after surgery.33 However, the determination of ipRGC
function using the blue PIPR may have potential to monitor or
determine progression in the later stages of the disease, espe-
cially if baseline measurements are available. Although our
exploratory study did not have enough cases to analyze ipRGC
function separately in the moderate and severe glaucoma pa-
tients, who were combined into one group, future research is
planned to explore its potential in differentiating between
these two groups. A further extension of this study will be to
use a range of stimulus irradiance levels to study how the PIPR
difference between the glaucoma patients and age-matched
controls depend on irradiance, and to determine the threshold
irradiance for detection of early glaucomatous change.
In summary, this exploratory study is the first demonstra-
tion that patients with advanced glaucoma have ipRGC dys-
function compared with patients with early glaucoma and
normal participants as determined by direct measurement of
ipRGC function with the PIPR. Future research is needed to
determine how ipRGC function can assist in the assignment of
prognosis, assessment of progression, and decision-making in
advanced glaucoma cases.
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